Strategic
Collaborations

Kemwell is the leading biologics contract development and manufacturing organization (CDMO) in Asia, serving global biopharmaceutical organizations with both clinical and commercial needs. Located in Bangalore, India, Kemwell provides customers with high-quality and cost-effective end to-end services for the development and manufacturing of mammalian cell culture-based products. Kemwell's facilities consist of cGMP drug substance manufacturing suites with over 5000L bioreactor capacity, sterile fill, and finish line to support process and analytical development for protein therapeutics such as monoclonal antibodies, bi-specific antibodies, and fusion proteins. Kemwell has worked on many R&D projects during the development and clinical phase for both novel biologics and biosimilars, and is the exclusive partner of RevOpsis Therapeutics for the manufacturing and commercialization of RO-104 for the Indian market.

For more information, please visit www.kemwellbiopharma.com.

Ora, Inc. is the world's leading full-service ophthalmic drug and device development firm. Bringing together the most extensive and experienced team of ophthalmic experts, R&D professionals, and management executives, Ora maximizes the value of new product initiatives. This collaboration will ensure RevOpsis is able to leverage Ora's unparalleled expertise throughout the development process, providing valuable guidance on IND-enabling work, regulatory strategy, and clinical development planning. By partnering with Ora, RevOpsis further strengthens its capabilities and reaffirms its dedication to accelerating the development of life-changing ophthalmic therapies.

For more information on Ora, please visit www.oraclinical.com and follow Ora on LinkedIn.

Known for nurturing groundbreaking research, MBC BioLabs is focused on empowering startups to make a global impact. More than just physical spaces, the facilities are innovation hubs, providing RevOpsis access to flexible and cost-effective lab space, the latest in scientific equipment, and comprehensive operational support. The RevOpsis research and development operations are located at MBC BioLabs in San Carlos, California, where we will leverage the vibrant ecosystem to innovate and grow as a forerunner in the biotech industry, helping to advance the life sciences and healthcare.

For more information on MBC BioLabs, please visit: MBC BioLabs.